Optimization of the dosage regimen of zoledronic acid with a kinetic-pharmacodynamic model and exposure-response analysis.
Saved in:
| Title: | Optimization of the dosage regimen of zoledronic acid with a kinetic-pharmacodynamic model and exposure-response analysis. |
|---|---|
| Authors: | Wang H; Department of Orthopedics, Peking University Third Hospital, Beijing, China.; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.; Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital Beijing, Beijing, China., Liu Q; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.; Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital Beijing, Beijing, China., Jiang M; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.; Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital Beijing, Beijing, China., Song C; Department of Orthopedics, Peking University Third Hospital, Beijing, China.; Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital Beijing, Beijing, China., Liu D; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.; Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital Beijing, Beijing, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2023 Sep 27; Vol. 14, pp. 1089774. Date of Electronic Publication: 2023 Sep 27 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37829305 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Optimization of the dosage regimen of zoledronic acid with a kinetic-pharmacodynamic model and exposure-response analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wang+H%22">Wang H</searchLink>; Department of Orthopedics, Peking University Third Hospital, Beijing, China.; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.; Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital Beijing, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Liu+Q%22">Liu Q</searchLink>; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.; Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital Beijing, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Jiang+M%22">Jiang M</searchLink>; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.; Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital Beijing, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Song+C%22">Song C</searchLink>; Department of Orthopedics, Peking University Third Hospital, Beijing, China.; Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital Beijing, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Liu+D%22">Liu D</searchLink>; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.; Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital Beijing, Beijing, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2023 Sep 27; Vol. 14, pp. 1089774. <i>Date of Electronic Publication: </i>2023 Sep 27 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37829305 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2023.1089774 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1089774 Titles: – TitleFull: Optimization of the dosage regimen of zoledronic acid with a kinetic-pharmacodynamic model and exposure-response analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang H – PersonEntity: Name: NameFull: Liu Q – PersonEntity: Name: NameFull: Jiang M – PersonEntity: Name: NameFull: Song C – PersonEntity: Name: NameFull: Liu D IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 09 Text: 2023 Sep 27 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |
